BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24200853)

  • 1. Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.
    Ghosh S; Sur S; Yerram SR; Rago C; Bhunia AK; Hossain MZ; Paun BC; Ren YR; Iacobuzio-Donahue CA; Azad NA; Kern SE
    Am J Pathol; 2014 Jan; 184(1):260-70. PubMed ID: 24200853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
    van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
    Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fanconi anemia/BRCA gene network in zebrafish: embryonic expression and comparative genomics.
    Titus TA; Yan YL; Wilson C; Starks AM; Frohnmayer JD; Bremiller RA; Cañestro C; Rodriguez-Mari A; He X; Postlethwait JH
    Mutat Res; 2009 Jul; 668(1-2):117-32. PubMed ID: 19101574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
    Snyder ER; Ricker JL; Chen Z; Waes CV
    Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.
    Yamamoto K; Ishiai M; Matsushita N; Arakawa H; Lamerdin JE; Buerstedde JM; Tanimoto M; Harada M; Thompson LH; Takata M
    Mol Cell Biol; 2003 Aug; 23(15):5421-30. PubMed ID: 12861027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Fanconi anemia/BRCA genes in zebrafish sex determination.
    Rodríguez-Marí A; Postlethwait JH
    Methods Cell Biol; 2011; 105():461-90. PubMed ID: 21951543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients.
    Mori M; Hira A; Yoshida K; Muramatsu H; Okuno Y; Shiraishi Y; Anmae M; Yasuda J; Tadaka S; Kinoshita K; Osumi T; Noguchi Y; Adachi S; Kobayashi R; Kawabata H; Imai K; Morio T; Tamura K; Takaori-Kondo A; Yamamoto M; Miyano S; Kojima S; Ito E; Ogawa S; Matsuo K; Yabe H; Yabe M; Takata M
    Haematologica; 2019 Oct; 104(10):1962-1973. PubMed ID: 30792206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
    van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
    Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.
    Gallmeier E; Calhoun ES; Rago C; Brody JR; Cunningham SC; Hucl T; Gorospe M; Kohli M; Lengauer C; Kern SE
    Gastroenterology; 2006 Jun; 130(7):2145-54. PubMed ID: 16762635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.
    Barroso E; Pita G; Arias JI; Menendez P; Zamora P; Blanco M; Benitez J; Ribas G
    Breast Cancer Res Treat; 2009 Dec; 118(3):655-60. PubMed ID: 19536649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
    Shen X; Do H; Li Y; Chung WH; Tomasz M; de Winter JP; Xia B; Elledge SJ; Wang W; Li L
    Mol Cell; 2009 Sep; 35(5):716-23. PubMed ID: 19748364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
    Reliene R; Yamamoto ML; Rao PN; Schiestl RH
    Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities.
    Naim V; Rosselli F
    Nat Cell Biol; 2009 Jun; 11(6):761-8. PubMed ID: 19465921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
    Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
    Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.